MANILA, Philippines — The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Sputnik V COVID-19 vaccine developed by Russia’s Gamaleya Institute.
“After a rigorous and thorough review, the FDA is granting EUA to the Sputnik V COVID-19 vaccine,” FDA Director General Eric Domingo announced on Friday.
This is the fourth vaccine that secured an EUA in the country.
Vaccine czar Carlito Galvez Jr. earlier said the Philippines may receive two million doses of the Sputnik V vaccine this April once it secures an EUA.
gsg
…
Keep on reading: Russia’s Sputnik V COVID-19 vaccine gets emergency use authorization